正在加载...

Advertisement

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

RTTNews | 631天前

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

(RTTNews) - Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter was $1.06 per share, compared to $0.62 per share in the year-ago quarter.

Total revenues for the quarter rose 9 percent to $1.01 billion from $926.70 million in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $1.16 per share on revenues of $1.0 billion for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2024, Incyte now projects Jakafi net product revenue in a range of $2.69 billion to $2.75 billion. Other Hematology/Oncology net product revenues are projected between $325 million and $360 million.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

标签: INCY

read more

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

RTTNews | 957天前

Incyte Q1 Results Top Estimates

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.

RTTNews | 1191天前

Hong Kong Bourse May Halt Its Slide On Thursday

Hong Kong Bourse May Halt Its Slide On Thursday

The Hong Kong stock market has moved lower in consecutive trading days, sinking more than 220 points or 0.8 percent along the way. The Hang Seng Index now rests just above the 25,930-point plateau although it may find traction on Thursday.

RTTNews | 1小时11分钟前

China Shares May Extend Wednesday's Gains

China Shares May Extend Wednesday's Gains

The China stock market has moved higher in two of three trading days since the end of the two-day slide in which it had dropped more than 60 points or 1.5 percent. The Shanghai Composite Index now sits just beneath the 3,970-point plateau and it may tick higher again on Thursday.

RTTNews | 1小时26分钟前

Australian Market Notably Higher

Australian Market Notably Higher

The Australian market is trading notably higher on Thursday, reversing some of the losses in the previous two sessions, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving well above the 8,800 level, with gains across most sectors led by mining and energy stocks amid rebounding commodity prices.

RTTNews | 1小时31分钟前

Japan Services PMI Eases To 53.1 In October - Jibun

Japan Services PMI Eases To 53.1 In October - Jibun

The services sector in Japan continued to expand in October, albeit at a slightly slower pace, the latest survey from Jibun Bank revealed on Thursday with a services PMI score of 53.1.

RTTNews | 1小时51分钟前

Taiwan Bourse Due For Support On Thursday

Taiwan Bourse Due For Support On Thursday

The Taiwan stock market has finished lower in back-to-back sessions, stumbling more than 640 points or 2.3 percent in that span. The Taiwan Stock Exchange now sits just beneath the 27,720-point plateau although it may stop the bleeding on Thursday.

RTTNews | 1小时56分钟前

Singapore Shares May Find Traction On Thursday

Singapore Shares May Find Traction On Thursday

The Singapore stock market has moved lower in two straight sessions, slumping more than 25 points or 0.6 percent along the way. The Straits Times Index now sits just beneath the 4,420-point plateau although it may find support on Thursday.

RTTNews | 2小时26分钟前

条款 | 隐私。 | 网站地图 | Site Map Calendar

© 2025 Myfxbook Ltd. All Rights Reserved.

高风险警告：外汇交易具有高风险，可能不适合所有投资者。杠杆创造了额外的风险和损失风险。在您决定进行外汇交易之前，仔细考虑您的投资目标、经验水平和风险承受能力。您可能会损失部分或全部的初始投资。不要投资您无法承受损失的钱。对自己进行与外汇交易有关的风险教育，如果您有任何问题，请向独立的财务或税务顾问咨询。任何数据和信息都是"按原样"提供的，仅仅是为了提供信息，并不打算用于交易目的或建议。过去的业绩并不代表未来的结果。